Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-16T08:44:51.876Z Has data issue: false hasContentIssue false
  • English
  • Français

Patents on Life: Religious, Moral, and Social Justice Aspects of Biotechnology and Intellectual Property. Edited by Thomas C. Berg, Roman Cholij, and Simon Ravenscroft. Cambridge: Cambridge University Press, 2019. Pp. 313. $110.00 (cloth); $88.00 (digital). ISBN: 9781108659802.

Published online by Cambridge University Press:  06 July 2021

Ira Bedzow
Ira Bedzow*
Affiliation:
Associate Professor of Medicine New York Medical College
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Book Review
Information
Journal of Law and Religion , Volume 36 , Issue 2 , August 2021 , pp. 433 - 435
Check for updates
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of the Center for the Study of Law and Religion at Emory University

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Office of the United States Trade Representative, “Statement from Ambassador Katherine Tai on the Covid-19 Trips Waiver,” May 5, 2021, https://ustr.gov/about-us/policy-offices/press-office/press-releases/2021/may/statement-ambassador-katherine-tai-covid-19-trips-waiver.

2 “Whose WTO Is It Anyway?, World Trade Organization, accessed May 20, 2021, https://www.wto.org/english/thewto_e/whatis_e/tif_e/org1_e.htm.

3 Madeline Chambers and Andreas Rinke, “Germany Rejects U.S. Proposal to Waive Patents on COVID-19 Vaccines,” Reuters, May 6, 2001, https://www.reuters.com/business/healthcare-pharmaceuticals/germany-opposes-us-plan-waive-patents-covid-19-vaccines-2021-05-06/.

4 David Ljunggren and Steve Scherer, “Canada Ready to Discuss COVID-19 Vaccine IP Waiver, ‘Not Interfering or Blocking’—Trudeau,” Reuters, May 7, 2021, https://www.reuters.com/world/americas/canada-willing-discuss-covid-19-vaccine-ip-waiver-statement-2021-05-07/; “China Backs Talks on Intellectual Property Waiver for COVID Vaccines,” Reuters, May 13, 2021, https://www.reuters.com/world/china/china-backs-talks-intellectual-property-waiver-covid-vaccines-2021-05-13/; Silvia Amaro, “EU Is ‘Ready’ to Talk about Waiving Patent Protections on Covid Vaccines, after U.S. Backs Move,” CNBC, May 6, 2021, https://www.cnbc.com/2021/05/06/covid-vaccine-eu-ready-to-talk-wave-of-ip-rights-after-us-backs-move.html.

5 Heinrichs, Melisa J. and Owens, Gary M., “Where Generics and Biologics Meet,” American Health & Drug Benefits 1, no. 5 (2008): 21–26Google ScholarPubMed, at 21.

6 Laura Smith-Spark, “Rich Nations Urged to Share Vaccine Knowledge as WTO Debates Waiving Patents,” CNN, May 5, 2021, https://edition.cnn.com/2021/05/05/world/covid-19-vaccine-patents-wto-intl/index.html.